Navigation Links
FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia
Date:5/21/2009

ter degree in SAMSCA-treated patients compared to placebo-treated patients as early as 8 hours after the first dose, and the change was maintained for 30 days. The percentage of patients requiring fluid restriction (defined as less than 1L/day at any time during the treatment period) was also significantly less (p less than 0.0017) in the SAMSCA-treated group (30/215, 14 percent) as compared with the placebo-treated group (51/206, 25 percent).

In an open-label study (SALTWATER), 111 patients, 94 of whom were hyponatremic, who had previously been treated with either placebo or SAMSCA (and who had returned to standard of care for at least 7 days), were administered SAMSCA. Upon initiation of therapy, average serum sodium concentrations increased to approximately the same levels as observed for those patients previously treated with SAMSCA and were sustained for at least a year.

The safety of SAMSCA has been evaluated in more than 4,000 patients, approximately 650 of which had hyponatremia. Of these 650 patients, approximately 219 received SAMSCA for six months or more. In the two 30-day, double-blind, placebo-controlled trials, the most common adverse reactions (greater than or equal to 5 percent more frequently than in patients receiving placebo) observed in patients receiving SAMSCA (n equals 223, placebo n equals 220) were thirst (16 percent vs. 5 percent in placebo patients), dry mouth (13 percent vs. 4 percent), asthenia (9 percent vs. 4 percent), constipation (7 percent vs. 2 percent), pollakiuria or polyuria (11 percent vs. 3 percent), and hyperglycemia (6 percent vs. 1 percent). In these studies, 10 percent of SAMSCA patients discontinued therapy due to adverse reactions compared to 12 percent of placebo-treated patients.

About Hyponatremia

Hyponatremia, a common electrolyte disorder in hospitals, occurs in as many as 6 million people in the United States or 15-20 percent of hospitalized p
'/>"/>

SOURCE Otsuka Pharmaceutical Co., Ltd.; Otsuka America Pharmaceutical, Inc.; Otsuka Pharmaceutical Development & Commercialization, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. FDA Approves First Anti-Psychotic for Kids
2. FDA Approves New Roche West Nile Virus Blood Screening Test
3. FDA Approves Osteoporosis Drug to Cut Breast Cancer Risk
4. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
5. FDA Approves SOMA(R) (carisoprodol) 250 mg
6. FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
7. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. ABIH Approves Certification Credit for SSPC Training Courses
10. FDA Approves REALIZE(TM) Adjustable Gastric Band for Morbid Obesity
11. FDA Approves New Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... Camden, NJ (PRWEB) July 28, 2014 ... to provide enhanced access and reduced wait times for ... only six hospital systems in the state—and the only ... HealthNet Federal Services Patient-Centered Community Care program (PC3). PC3 ... Veterans Administration (VA) hospital cannot provide services due to ...
(Date:7/28/2014)... near green spaces deliver babies with significantly higher ... Spaces and Adverse Pregnancy Outcomes" published in the ... A team of researchers from Israel and Spain, ... nearly 40,000 single live births from a registry ... the impact of green surroundings during pregnancy and ...
(Date:7/28/2014)... Drorit Silverman, a professional bodybuilder and chiropractor ... investment capital through her crowd funding camping to tap ... States. , According to a statement released by Drorit ... a great window of opportunity for investors like her ... to this, Silverman looks at the 24/7 fitness concept ...
(Date:7/28/2014)... July 28, 2014 Qualis Health, ... care management organizations, has published a complimentary, online ... to engaging patients and families in infection control. ... multiple hospitals, the toolkit provides a step-by-step roadmap ... patients and their families early in a hospital ...
(Date:7/28/2014)... MONDAY, July 28, 2014 (HealthDay News) -- A ... stiffness in older people may increase the risk ... suggests. A British study found that patients ... vascular disease -- conditions that affect the blood ... factors of patients with polymyalgia rheumatica to reduce ...
Breaking Medicine News(10 mins):Health News:Lourdes Expands Military Partnership with Veterans 2Health News:Lourdes Expands Military Partnership with Veterans 3Health News:Pro Bodybuilder Drorit Silverman Confirms Plans to Raise Money for Investment in the Popular 24/7 Fitness Concept 2Health News:Patient Engagement in Hospital Infection Control: Online Toolkit Provides a New Solution 2Health News:Inflammatory Muscle Disorder May Raise Risk for Heart Attack, Stroke 2
... March 24 Avidas(TM) Pharmaceuticals, a privately held, ... women,s health, today announced the launch of Scalacort(TM) ... in one patient convenience kit.Scalacort DK includes Scalacort ... in a clear fragrance-free base. Scalacort relieves itching ...
... since the 1994 federal health reform debate is chronicled ... Week,PRINCETON, N.J., March 24 With Congress and the ... care system, a new report looks at what has ... 1994 without any comprehensive congressional action. The analysis from ...
... Syndromic Surveillance CapabilitiesSAN DIEGO, March 24 Crossflo ... Board: PTSC) an innovative provider of data-sharing solutions ... focused on implementing a data sharing system for ... State of Montana. The Crossflo DataExchange(R) Server ...
... Arizona Attorney General,s Office has opened an investigation ... Action released videos with undercover footage from three ... two Planned Parenthood clinics in Phoenix, AZ and ... laws for sexual abuse, and offering secret abortions ...
... call for better measurement and transparency as foundation for ... a diverse coalition of more than 165 organizations from ... to improve the quality and affordability of health care ... six key recommendations.The six recommendations are: , , ...
... are bringing more than May flowers. April Rain® is springing to ... their brand new product, Day Rainew®. April Rain® is lighting up ... skin solution to battle extreme stressors and any environmental factors. , ... ...
Cached Medicine News:Health News:Avidas(TM) Pharmaceuticals Introduces Scalacort(TM) DK Which Offers Three Scalp Solutions in One Patient Convenience Kit 2Health News:Avidas(TM) Pharmaceuticals Introduces Scalacort(TM) DK Which Offers Three Scalp Solutions in One Patient Convenience Kit 3Health News:More Working People Go Without Health Coverage as Insurance Costs Outpace Income 2Health News:More Working People Go Without Health Coverage as Insurance Costs Outpace Income 3Health News:More Working People Go Without Health Coverage as Insurance Costs Outpace Income 4Health News:Crossflo Provides Data Sharing for Montana Health Information Exchange 2Health News:Crossflo Provides Data Sharing for Montana Health Information Exchange 3Health News:Arizona Attorney General to Investigate Sexual Abuse Cover Up at Planned Parenthood Clinics 2Health News:Broad Coalition Offers Plan to Improve Health Care Quality and Affordability 2Health News:Broad Coalition Offers Plan to Improve Health Care Quality and Affordability 3Health News:April Rain is Protecting Skin with The Launch of Day Rainew 2Health News:April Rain is Protecting Skin with The Launch of Day Rainew 3
(Date:7/28/2014)... -- Concord Medical Services Holdings Limited ("Concord Medical" or ... specialty hospital management solution provider and operator of the ... China , today announced that on ... special cash dividend of US$0.30 per ordinary share (or ... outstanding ordinary shares. The total expense for the special ...
(Date:7/28/2014)... TOKYO , July 28, 2014 /PRNewswire/ ... appointed Roger Crystal , MD as Vice President ... the Global Business Development Product Acquisition & Licensing team ... in developing business strategy and partnerships in the precision ... to partner with biotechnology and pharmaceutical companies across the ...
(Date:7/28/2014)... , July 28, 2014   Cardioxyl Pharmaceuticals, ... clinical trial demonstrating that CXL-1427, a novel potential treatment ... in healthy volunteers. The company has now initiated dosing ... Phase IIa clinical trial designed to further evaluate the ... levels. The Phase I clinical trial evaluated ...
Breaking Medicine Technology:Concord Medical Declares Special Dividend 2ImaginAb Appoints Roger Crystal, MD as Vice President of Business Development 2Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial For Heart Failure Drug CXL-1427 2
... , CHICAGO , July 30 ... equity firm focused exclusively on health care, announced today ... (MSD).  Headquartered in Stoughton, Massachusetts , MSD ... biomedical services and technology solutions to the growing home ...
... , CATANIA, Italy , July 30 ... European research project today announced details of the ... three-year ENIAC (European Nanoelectronics Initiative Advisory Council) project ... 3D-imaging platforms by focusing on the diagnosis and ...
Cached Medicine Technology:Water Street Healthcare Partners Announces New Investment in Medical Specialties Distributors, LLC 2Water Street Healthcare Partners Announces New Investment in Medical Specialties Distributors, LLC 3Water Street Healthcare Partners Announces New Investment in Medical Specialties Distributors, LLC 4European Research Project Aims to Improve the Diagnosis and Therapy of Brain Diseases 2European Research Project Aims to Improve the Diagnosis and Therapy of Brain Diseases 3
The MPF cup is specifically designed to achieve high primary stability, a critical factor for long term success....
The cementless biomEx cup can be used with both cemented and cementless femoral stems....
Trident Hemispherical Acetabular Shells are a true hemispherical shape designed to achieve press-fit fixation by under-reaming the acetabulum....
For primary and revision cases...
Medicine Products: